Cargando…
Outcome after intensity modulated radiotherapy for anaplastic thyroid carcinoma
BACKGROUND: Anaplastic thyroid carcinoma (ATC) is a malignancy with one of the highest fatality rates. We reviewed our recent clinical experience with intensity modulated radiotherapy (IMRT) combined with surgery and chemotherapy for the management of ATC. METHODS: 13 patients with ATC who were trea...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3976675/ https://www.ncbi.nlm.nih.gov/pubmed/24690325 http://dx.doi.org/10.1186/1471-2407-14-235 |
_version_ | 1782310317478379520 |
---|---|
author | He, Xiayun Li, Duanshu Hu, Chaosu Wang, Zhuoying Ying, Hongmei Wu, Yi |
author_facet | He, Xiayun Li, Duanshu Hu, Chaosu Wang, Zhuoying Ying, Hongmei Wu, Yi |
author_sort | He, Xiayun |
collection | PubMed |
description | BACKGROUND: Anaplastic thyroid carcinoma (ATC) is a malignancy with one of the highest fatality rates. We reviewed our recent clinical experience with intensity modulated radiotherapy (IMRT) combined with surgery and chemotherapy for the management of ATC. METHODS: 13 patients with ATC who were treated by IMRT in our institution between October 2008 and February 2011, have been analyzed. The target volume for IMRT was planned to include Gross tumor volume (GTV): primary tumor plus any N + disease (66 Gy/33 F/6.6 W), with elective irradiation of thyroid bed, bilateral level II through VI and mediastinal lymph nodes to the level of the carina (54-60 Gy). Seven patients received surgical intervention and eleven patients had chemotherapy. RESULTS: The median radiotherapy dose to GTV was 60 Gy/30 fractions/6 weeks. The median survival time of the 13 patients was 9 months. The direct causes of death were distant metastases (75%) and progression of the locoregional disease (25%). Ten patients were spared dyspnea and tracheostomy because their primary neck lesion did not progress. CONCLUSION: The results showed that IMRT combined by surgery and chemotherapy for ATC might be beneficial to improve locoregional control. Further new therapies are needed to control metastases. |
format | Online Article Text |
id | pubmed-3976675 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-39766752014-04-06 Outcome after intensity modulated radiotherapy for anaplastic thyroid carcinoma He, Xiayun Li, Duanshu Hu, Chaosu Wang, Zhuoying Ying, Hongmei Wu, Yi BMC Cancer Research Article BACKGROUND: Anaplastic thyroid carcinoma (ATC) is a malignancy with one of the highest fatality rates. We reviewed our recent clinical experience with intensity modulated radiotherapy (IMRT) combined with surgery and chemotherapy for the management of ATC. METHODS: 13 patients with ATC who were treated by IMRT in our institution between October 2008 and February 2011, have been analyzed. The target volume for IMRT was planned to include Gross tumor volume (GTV): primary tumor plus any N + disease (66 Gy/33 F/6.6 W), with elective irradiation of thyroid bed, bilateral level II through VI and mediastinal lymph nodes to the level of the carina (54-60 Gy). Seven patients received surgical intervention and eleven patients had chemotherapy. RESULTS: The median radiotherapy dose to GTV was 60 Gy/30 fractions/6 weeks. The median survival time of the 13 patients was 9 months. The direct causes of death were distant metastases (75%) and progression of the locoregional disease (25%). Ten patients were spared dyspnea and tracheostomy because their primary neck lesion did not progress. CONCLUSION: The results showed that IMRT combined by surgery and chemotherapy for ATC might be beneficial to improve locoregional control. Further new therapies are needed to control metastases. BioMed Central 2014-04-02 /pmc/articles/PMC3976675/ /pubmed/24690325 http://dx.doi.org/10.1186/1471-2407-14-235 Text en Copyright © 2014 He et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. |
spellingShingle | Research Article He, Xiayun Li, Duanshu Hu, Chaosu Wang, Zhuoying Ying, Hongmei Wu, Yi Outcome after intensity modulated radiotherapy for anaplastic thyroid carcinoma |
title | Outcome after intensity modulated radiotherapy for anaplastic thyroid carcinoma |
title_full | Outcome after intensity modulated radiotherapy for anaplastic thyroid carcinoma |
title_fullStr | Outcome after intensity modulated radiotherapy for anaplastic thyroid carcinoma |
title_full_unstemmed | Outcome after intensity modulated radiotherapy for anaplastic thyroid carcinoma |
title_short | Outcome after intensity modulated radiotherapy for anaplastic thyroid carcinoma |
title_sort | outcome after intensity modulated radiotherapy for anaplastic thyroid carcinoma |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3976675/ https://www.ncbi.nlm.nih.gov/pubmed/24690325 http://dx.doi.org/10.1186/1471-2407-14-235 |
work_keys_str_mv | AT hexiayun outcomeafterintensitymodulatedradiotherapyforanaplasticthyroidcarcinoma AT liduanshu outcomeafterintensitymodulatedradiotherapyforanaplasticthyroidcarcinoma AT huchaosu outcomeafterintensitymodulatedradiotherapyforanaplasticthyroidcarcinoma AT wangzhuoying outcomeafterintensitymodulatedradiotherapyforanaplasticthyroidcarcinoma AT yinghongmei outcomeafterintensitymodulatedradiotherapyforanaplasticthyroidcarcinoma AT wuyi outcomeafterintensitymodulatedradiotherapyforanaplasticthyroidcarcinoma |